Cargando…

Correction to “Pneumococcal vaccine uptake and vaccine effectiveness in older adults with invasive pneumococcal disease in Germany: A retrospective cohort study”

Detalles Bibliográficos
Autores principales:	Perniciaro, Stephanie, van der Linden, Mark
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Corrections
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160313/ https://www.ncbi.nlm.nih.gov/pubmed/35663361 http://dx.doi.org/10.1016/j.lanepe.2022.100409

Ejemplares similares

Pneumococcal vaccine uptake and vaccine effectiveness in older adults with invasive pneumococcal disease in Germany: A retrospective cohort study
por: Perniciaro, Stephanie, et al.
Publicado: (2021)

Effects of Infant Pneumococcal Conjugate Vaccination on Serotype Distribution in Invasive Pneumococcal Disease among Children and Adults in Germany
por: van der Linden, Mark, et al.
Publicado: (2015)

Correction: Limited indirect effects of an infant pneumococcal vaccination program in an aging population
por: van der Linden, Mark, et al.
Publicado: (2020)

Invasive Pneumococcal Disease in Refugee Children, Germany
por: Perniciaro, Stephanie, et al.
Publicado: (2018)

Effectiveness of Pneumococcal Conjugate Vaccines (PCV7 and PCV13) against Invasive Pneumococcal Disease among Children under Two Years of Age in Germany
por: van der Linden, Mark, et al.
Publicado: (2016)

Reemergence of Invasive Pneumococcal Disease in Germany During the Spring and Summer of 2021( )
por: Perniciaro, Stephanie, et al.
Publicado: (2022)

Regional variations in serotype distribution and vaccination status in children under six years of age with invasive pneumococcal disease in Germany
por: Perniciaro, Stephanie, et al.
Publicado: (2019)

Pneumococcal meningitis and vaccine effects in the era of conjugate vaccination: results of 20 years of nationwide surveillance in Germany
por: Imöhl, Matthias, et al.
Publicado: (2015)

Limited indirect effects of an infant pneumococcal vaccination program in an aging population
por: van der Linden, Mark, et al.
Publicado: (2019)

Effect of heptavalent pneumococcal conjugate vaccination on invasive pneumococcal disease in preterm born infants
por: Rückinger, Simon, et al.
Publicado: (2010)

Correction: Invasive pneumococcal diseases in children and adults before and after introduction of the 10-valent pneumococcal conjugate vaccine into the Austrian national immunization program
por: Richter, Lukas, et al.
Publicado: (2019)

Uptake of pneumococcal vaccination in older people in northern Israel
por: Eilat-Tsanani, Sophia, et al.
Publicado: (2021)

Correction to: Estimates of the Health and Economic Burden of Pneumococcal Infections Attributable to the 15-Valent Pneumococcal Conjugate Vaccine Serotypes in the USA
por: Owusu-Edusei, Kwame, et al.
Publicado: (2022)

Older adults’ vaccine hesitancy: psychosocial predictors of influenza, pneumococcal, & shingles vaccine uptake
por: Nicholls, Louise Brown, et al.
Publicado: (2020)

2711. Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Invasive Pneumococcal Disease in Older Adults
por: Lewis, Ned, et al.
Publicado: (2019)

Invasive Pneumococcal Disease and 7-Valent Pneumococcal Conjugate Vaccine, the Netherlands
por: van Deursen, Anna M.M., et al.
Publicado: (2012)

Correction to: Estimating the Public Health and Economic Impact of Introducing the 13-Valent Pneumococcal Conjugate Vaccine or 10-Valent Pneumococcal Conjugate Vaccines into State Immunization Programs in India
por: Ghia, Canna J., et al.
Publicado: (2021)

Comparison of the Impact of Pneumococcal Conjugate Vaccine 10 or Pneumococcal Conjugate Vaccine 13 on Invasive Pneumococcal Disease in Equivalent Populations
por: Naucler, Pontus, et al.
Publicado: (2017)

Dynamic models of pneumococcal carriage and the impact of the Heptavalent Pneumococcal Conjugate Vaccine on invasive pneumococcal disease
por: Melegaro, Alessia, et al.
Publicado: (2010)

Nasopharyngeal Carriage in Children After the Introduction of Generalized Infant Pneumococcal Conjugate Vaccine Immunization in Germany
por: Rose, Markus A., et al.
Publicado: (2021)

Temporal Variations among Invasive Pneumococcal Disease Serotypes in Children and Adults in Germany (1992–2008)
por: Imöhl, Matthias, et al.
Publicado: (2010)

Correction: Genetic diversity of pneumococcal surface protein A in invasive pneumococcal isolates from Korean children, 1991-2016
por: Yun, Ki Wook, et al.
Publicado: (2018)

Pneumococcal vaccination of older adults: Conjugate or polysaccharide?
por: Hollingsworth, Rosalind, et al.
Publicado: (2014)

Recent Topics of Pneumococcal Vaccination: Indication of Pneumococcal Vaccine for Individuals at a Risk of Pneumococcal Disease in Adults
por: Asai, Nobuhiro, et al.
Publicado: (2021)

Potential cost-effectiveness and benefit-cost ratios of adult pneumococcal vaccination in Germany
por: Kuhlmann, Alexander, et al.
Publicado: (2012)

Serologic response to pneumococcal vaccination in children experiencing recurrent invasive pneumococcal disease
por: Ingels, Helene A. S., et al.
Publicado: (2018)

Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease in Greenland
por: Nikolova, Kristiana Alexandrova, et al.
Publicado: (2021)

Impact of national pneumococcal vaccination program on invasive pneumococcal diseases in South Korea
por: Jung, Yeon Haw, et al.
Publicado: (2022)

Recent Trends in Invasive Pneumococcal Disease in Korea in the Post-pneumococcal Vaccine Era
por: Huh, Hee Jae, et al.
Publicado: (2023)

Complicated Invasive Pneumococcal Meningitis: Highlighting the Value of Implementing New Pneumococcal Vaccines
por: Thacker, Stephen A
Publicado: (2023)

Effectiveness of the 23-valent polysaccharide pneumococcal vaccine against invasive pneumococcal disease in people 60 years or older
por: Vila-Corcoles, Angel, et al.
Publicado: (2010)

Global Control of Pneumococcal Infections by Pneumococcal Vaccines
por: Oishi, Kazunori, et al.
Publicado: (2014)

Pneumococcal disease and use of pneumococcal vaccines in Taiwan
por: Wei, Sung-Hsi, et al.
Publicado: (2015)

Correction: Impact of 13-valent pneumococcal conjugate vaccine on laboratory-confirmed pneumococcal meningitis and purulent meningitis among children ˂5 years in Cameroon, 2011–2018
Publicado: (2021)

Estimating the cost-effectiveness of a sequential pneumococcal vaccination program for adults in Germany
por: Kuchenbecker, Ulrike, et al.
Publicado: (2018)

Sex differences in invasive pneumococcal disease and the impact of pneumococcal conjugate vaccination in the Netherlands, 2004 to 2015
por: Wagenvoort, Gertjan H J, et al.
Publicado: (2017)

Missed Pneumococcal Vaccination Opportunities in Adults With Invasive Pneumococcal Disease in a Community Health System
por: Schulz, Paul S, et al.
Publicado: (2022)

Incidence of invasive pneumococcal disease after introduction of the 13-valent conjugate pneumococcal vaccine in British Columbia: A retrospective cohort study
por: Vadlamudi, Nirma Khatri, et al.
Publicado: (2020)

Correction: Host Factors and Biomarkers Associated with Poor Outcomes in Adults with Invasive Pneumococcal Disease
por: Hanada, Shigeo, et al.
Publicado: (2016)

Increase of serotypes 15A and 23B in IPD in Germany in the PCV13 vaccination era
por: van der Linden, Mark, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_9gp668atslgkr29k96a2hfvnm8